Shares of Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF – Get Free Report) saw unusually-high trading volume on Tuesday . 1,125 shares were traded during trading, an increase of 41% from the previous session’s volume of 796 shares.The stock last traded at $20.1150 and had previously closed at $19.9460.
Hikma Pharmaceuticals Trading Up 0.8%
The firm’s 50-day moving average price is $19.16 and its two-hundred day moving average price is $19.40. The company has a current ratio of 1.82, a quick ratio of 1.06 and a debt-to-equity ratio of 0.57.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals is a multinational pharmaceutical company that develops, manufactures and markets a broad range of branded and non-branded generics, specialty injectables and consumer healthcare products. The company’s three core business segments include generic medicines, injectable products and branded generics, serving hospitals, wholesalers and pharmacies worldwide. Its product portfolio spans diverse therapeutic areas such as cardiovascular, oncology, respiratory, pain management and anti-infectives, with an emphasis on injectable solutions for complex hospital treatments.
Founded in 1978 in Amman, Jordan, Hikma has grown through organic expansion and strategic acquisitions to become one of the leading pharmaceutical players in the Middle East, North Africa, Europe and the United States.
Read More
- Five stocks we like better than Hikma Pharmaceuticals
- Rocket Lab Defies Gravity With $8B Buyout
- Even CEOs Need Cash: Insider Selling Is Not the Only Signal in AI Stocks
- The Quantum Bubble Is Real Enough to Take Seriously
- Why Wall Street Still Sees Massive Upside for AeroVironment Stock
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
